Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 46

1.

Enterobacter spp.: Update on Taxonomy, Clinical Aspects, and Emerging Antimicrobial Resistance.

Davin-Regli A, Lavigne JP, Pagès JM.

Clin Microbiol Rev. 2019 Jul 17;32(4). pii: e00002-19. doi: 10.1128/CMR.00002-19. Print 2019 Sep 18. Review.

PMID:
31315895
2.

Modification of outer membrane permeability and alteration of LPS in veterinary enterotoxigenic Escherichia coli.

Davin-Regli A, Guerin-Faublée V, Pagès JM.

Res Vet Sci. 2019 Jun;124:321-327. doi: 10.1016/j.rvsc.2019.04.011. Epub 2019 Apr 16.

PMID:
31035220
3.

Modulation of antimicrobial resistance in clinical isolates of Enterobacter aerogenes: A strategy combining antibiotics and chemosensitisers.

McCusker MP, Alves Ferreira D, Cooney D, Martins Alves B, Fanning S, Pagès JM, Martins M, Davin-Regli A.

J Glob Antimicrob Resist. 2019 Mar;16:187-198. doi: 10.1016/j.jgar.2018.10.009. Epub 2018 Oct 12.

PMID:
30321623
4.

Ram locus is a key regulator to trigger multidrug resistance in Enterobacter aerogenes.

Molitor A, James CE, Fanning S, Pagès JM, Davin-Regli A.

J Med Microbiol. 2018 Feb;67(2):148-159. doi: 10.1099/jmm.0.000667. Epub 2018 Jan 3.

PMID:
29297851
5.

Porin flexibility in Providencia stuartii: cell-surface-exposed loops L5 and L7 are markers of Providencia porin OmpPst1.

Tran QT, Maigre L, D'Agostino T, Ceccarelli M, Winterhalter M, Pagès JM, Davin-Regli A.

Res Microbiol. 2017 Oct;168(8):685-699. doi: 10.1016/j.resmic.2017.05.003. Epub 2017 May 30.

PMID:
28576703
6.

In Vivo Evolution of Bacterial Resistance in Two Cases of Enterobacter aerogenes Infections during Treatment with Imipenem.

Philippe N, Maigre L, Santini S, Pinet E, Claverie JM, Davin-Régli AV, Pagès JM, Masi M.

PLoS One. 2015 Sep 23;10(9):e0138828. doi: 10.1371/journal.pone.0138828. eCollection 2015.

7.

Role of the culture medium in porin expression and piperacillin-tazobactam susceptibility in Escherichia coli.

Pinet E, Franceschi C, Davin-Regli A, Zambardi G, Pagès JM.

J Med Microbiol. 2015 Nov;64(11):1305-14. doi: 10.1099/jmm.0.000152. Epub 2015 Aug 3.

PMID:
26242994
8.

Enterobacter aerogenes and Enterobacter cloacae; versatile bacterial pathogens confronting antibiotic treatment.

Davin-Regli A, Pagès JM.

Front Microbiol. 2015 May 18;6:392. doi: 10.3389/fmicb.2015.00392. eCollection 2015. Review.

9.

Phenotypic changes contributing to Enterobacter gergoviae biocide resistance.

Périamé M, Philippe N, Condell O, Fanning S, Pagès JM, Davin-Regli A.

Lett Appl Microbiol. 2015 Aug;61(2):121-9. doi: 10.1111/lam.12435. Epub 2015 May 29.

10.

Faecal carriage of carbapenemase-producing Gram-negative bacilli in hospital settings in southern France.

Pantel A, Marchandin H, Prère MF, Boutet-Dubois A, Brieu-Roche N, Gaschet A, Davin-Regli A, Sotto A, Lavigne JP.

Eur J Clin Microbiol Infect Dis. 2015 May;34(5):899-904. doi: 10.1007/s10096-014-2298-1. Epub 2014 Dec 23.

PMID:
25532506
11.

Enterobacter gergoviae membrane modifications are involved in the adaptive response to preservatives used in cosmetic industry.

Périamé M, Pagès JM, Davin-Regli A.

J Appl Microbiol. 2015 Jan;118(1):49-61. doi: 10.1111/jam.12676. Epub 2014 Nov 25.

12.

Enterobacter gergoviae adaptation to preservatives commonly used in cosmetic industry.

Périamé M, Pagès JM, Davin-Regli A.

Int J Cosmet Sci. 2014 Aug;36(4):386-95. doi: 10.1111/ics.12140. Epub 2014 Jul 1.

PMID:
24828151
13.

Faecal carriage of oxyiminocephalosporin-resistant Enterobacteriaceae among paediatric units in different hospitals in the south of France.

Boutet-Dubois A, Pantel A, Prère MF, Bellon O, Brieu-Roche N, Lecaillon E, Le Coustumier A, Davin-Regli A, Villeneuve L, Bouziges N, Gleize E, Lamarca R, Dunyach-Remy C, Sotto A, Lavigne JP.

Eur J Clin Microbiol Infect Dis. 2013 Aug;32(8):1063-8. doi: 10.1007/s10096-013-1851-7. Epub 2013 Mar 15.

PMID:
23494770
14.

An adaptive response of Enterobacter aerogenes to imipenem: regulation of porin balance in clinical isolates.

Lavigne JP, Sotto A, Nicolas-Chanoine MH, Bouziges N, Pagès JM, Davin-Regli A.

Int J Antimicrob Agents. 2013 Feb;41(2):130-6. doi: 10.1016/j.ijantimicag.2012.10.010. Epub 2012 Dec 29.

PMID:
23280442
15.

Antibiotic uptake through membrane channels: role of Providencia stuartii OmpPst1 porin in carbapenem resistance.

Bajaj H, Tran QT, Mahendran KR, Nasrallah C, Colletier JP, Davin-Regli A, Bolla JM, Pagès JM, Winterhalter M.

Biochemistry. 2012 Dec 21;51(51):10244-9. doi: 10.1021/bi301398j. Epub 2012 Dec 11.

PMID:
23210483
16.

Cross-resistance between biocides and antimicrobials: an emerging question.

Davin-Regli A, Pagès JM.

Rev Sci Tech. 2012 Apr;31(1):89-104. Review.

17.

Membrane permeability, a pivotal function involved in antibiotic resistance and virulence in Enterobacter aerogenes clinical isolates.

Lavigne JP, Sotto A, Nicolas-Chanoine MH, Bouziges N, Bourg G, Davin-Regli A, Pagès JM.

Clin Microbiol Infect. 2012 Jun;18(6):539-45. doi: 10.1111/j.1469-0691.2011.03607.x. Epub 2011 Aug 29.

18.

Physiological characterisation of the efflux pump system of antibiotic-susceptible and multidrug-resistant Enterobacter aerogenes.

Martins A, Spengler G, Martins M, Rodrigues L, Viveiros M, Davin-Regli A, Chevalier J, Couto I, Pagès JM, Amaral L.

Int J Antimicrob Agents. 2010 Oct;36(4):313-8. doi: 10.1016/j.ijantimicag.2010.06.036. Epub 2010 Aug 4.

PMID:
20688487
19.

Implication of porins in beta-lactam resistance of Providencia stuartii.

Tran QT, Mahendran KR, Hajjar E, Ceccarelli M, Davin-Regli A, Winterhalter M, Weingart H, Pagès JM.

J Biol Chem. 2010 Oct 15;285(42):32273-81. doi: 10.1074/jbc.M110.143305. Epub 2010 Jul 28.

20.

Efflux pumps of gram-negative bacteria, a new target for new molecules.

Pagès JM, Sandrine AF, Mahamoud A, Bolla JM, Davin-Regli A, Chevalier J, Garnotel E.

Curr Top Med Chem. 2010;10(18):1848-57.

PMID:
20615189
21.

Occurrence of efflux mechanism and cephalosporinase variant in a population of Enterobacter aerogenes and Klebsiella pneumoniae isolates producing extended-spectrum beta-lactamases.

Tran QT, Dupont M, Lavigne JP, Chevalier J, Pagès JM, Sotto A, Davin-Regli A.

Antimicrob Agents Chemother. 2009 Apr;53(4):1652-6. doi: 10.1128/AAC.00822-08. Epub 2009 Jan 21.

22.

Efflux mechanism, an attractive target to combat multidrug resistant Plasmodium falciparum and Pseudomonas aeruginosa.

Alibert-Franco S, Pradines B, Mahamoud A, Davin-Regli A, Pagès JM.

Curr Med Chem. 2009;16(3):301-17. Review.

PMID:
19149579
23.

Identification and evolution of drug efflux pump in clinical Enterobacter aerogenes strains isolated in 1995 and 2003.

Chevalier J, Mulfinger C, Garnotel E, Nicolas P, Davin-Régli A, Pagès JM.

PLoS One. 2008 Sep 12;3(9):e3203. doi: 10.1371/journal.pone.0003203.

24.

Membrane permeability and regulation of drug "influx and efflux" in enterobacterial pathogens.

Davin-Regli A, Bolla JM, James CE, Lavigne JP, Chevalier J, Garnotel E, Molitor A, Pagès JM.

Curr Drug Targets. 2008 Sep;9(9):750-9. Review.

PMID:
18781921
25.

Antibiotic stress, genetic response and altered permeability of E. coli.

Viveiros M, Dupont M, Rodrigues L, Couto I, Davin-Regli A, Martins M, Pagès JM, Amaral L.

PLoS One. 2007 Apr 11;2(4):e365.

26.

Quinoline derivatives as promising inhibitors of antibiotic efflux pump in multidrug resistant Enterobacter aerogenes isolates.

Mahamoud A, Chevalier J, Davin-Regli A, Barbe J, Pagès JM.

Curr Drug Targets. 2006 Jul;7(7):843-7. Review.

PMID:
16842215
27.

Enterobacter gergoviae and the prevalence of efflux in parabens resistance.

Davin-Regli A, Chollet R, Bredin J, Chevalier J, Lepine F, Pagès JM.

J Antimicrob Chemother. 2006 Apr;57(4):757-60. Epub 2006 Feb 10.

PMID:
16473920
28.

Propyl paraben induces potassium efflux in Escherichia coli.

Bredin J, Davin-Régli A, Pagès JM.

J Antimicrob Chemother. 2005 Jun;55(6):1013-5. Epub 2005 Apr 11.

PMID:
15824091
29.

RamA is an alternate activator of the multidrug resistance cascade in Enterobacter aerogenes.

Chollet R, Chevalier J, Bollet C, Pages JM, Davin-Regli A.

Antimicrob Agents Chemother. 2004 Jul;48(7):2518-23.

30.

Omp35, a new Enterobacter aerogenes porin involved in selective susceptibility to cephalosporins.

Bornet C, Saint N, Fetnaci L, Dupont M, Davin-Régli A, Bollet C, Pagès JM.

Antimicrob Agents Chemother. 2004 Jun;48(6):2153-8.

31.

Resistance to imipenem, cefepime, and cefpirome associated with mutation in Omp36 osmoporin of Enterobacter aerogenes.

Thiolas A, Bornet C, Davin-Régli A, Pagès JM, Bollet C.

Biochem Biophys Res Commun. 2004 May 7;317(3):851-6.

PMID:
15081418
32.

Imipenem and expression of multidrug efflux pump in Enterobacter aerogenes.

Bornet C, Chollet R, Malléa M, Chevalier J, Davin-Regli A, Pagès JM, Bollet C.

Biochem Biophys Res Commun. 2003 Feb 21;301(4):985-90.

PMID:
12589810
33.

mar Operon involved in multidrug resistance of Enterobacter aerogenes.

Chollet R, Bollet C, Chevalier J, Malléa M, Pagès JM, Davin-Regli A.

Antimicrob Agents Chemother. 2002 Apr;46(4):1093-7.

34.

Imipenem resistance of enterobacter aerogenes mediated by outer membrane permeability.

Bornet C, Davin-Regli A, Bosi C, Pages JM, Bollet C.

J Clin Microbiol. 2000 Mar;38(3):1048-52.

35.

Most Enterobacter aerogenes strains in France belong to a prevalent clone.

Bosi C, Davin-Regli A, Bornet C, Mallea M, Pages JM, Bollet C.

J Clin Microbiol. 1999 Jul;37(7):2165-9.

36.

A cluster of cases of infections due to Aeromonas hydrophila revealed by combined RAPD and ERIC-PCR.

Davin-Regli A, Bollet C, Chamorey E, Colonna D'istria V, Cremieux A.

J Med Microbiol. 1998 Jun;47(6):499-504.

PMID:
9879968
37.

Porin alteration and active efflux: two in vivo drug resistance strategies used by Enterobacter aerogenes.

Mallea M, Chevalier J, Bornet C, Eyraud A, Davin-Regli A, Bollet C, Pagès JM.

Microbiology. 1998 Nov;144 ( Pt 11):3003-9.

PMID:
9846735
38.

A nosocomial outbreak due to Enterobacter cloacae strains with the E. hormaechei genotype in patients treated with fluoroquinolones.

Davin-Regli A, Bosi C, Charrel R, Ageron E, Papazian L, Grimont PA, Cremieux A, Bollet C.

J Clin Microbiol. 1997 Apr;35(4):1008-10.

39.

Epidemiological investigation of Pseudomonas aeruginosa nosocomial bacteraemia isolates by PCR-based DNA fingerprinting analysis.

Liu Y, Davin-Regli A, Bosi C, Charrel RN, Bollet C.

J Med Microbiol. 1996 Nov;45(5):359-65.

PMID:
8918952
40.

Serratia marcescens nosocomial outbreak due to contamination of hexetidine solution.

Bosi C, Davin-Regli A, Charrel R, Rocca B, Monnet D, Bollet C.

J Hosp Infect. 1996 Jul;33(3):217-24.

PMID:
8827508
41.

Molecular epidemiology of Enterobacter aerogenes acquisition: one-year prospective study in two intensive care units.

Davin-Regli A, Monnet D, Saux P, Bosi C, Charrel R, Barthelemy A, Bollet C.

J Clin Microbiol. 1996 Jun;34(6):1474-80.

42.
43.

Use of random amplified polymorphic DNA for epidemiological typing of Stenotrophomonas maltophilia.

Davin-Regli A, Bollet C, Auffray JP, Saux P, De Micco P.

J Hosp Infect. 1996 Jan;32(1):39-50.

PMID:
8904371
44.

Variations in DNA concentrations significantly affect the reproducibility of RAPD fingerprint patterns.

Davin-Regli A, Abed Y, Charrel RN, Bollet C, de Micco P.

Res Microbiol. 1995 Sep;146(7):561-8.

PMID:
8577997
45.
46.

A Simple Method for Selective Isolation of Stenotrophomonas maltophilia from Environmental Samples.

Bollet C, Davin-Regli A, De Micco P.

Appl Environ Microbiol. 1995 Apr;61(4):1653-4.

Supplemental Content

Loading ...
Support Center